Recombinant Human Granulocyte Colony-Stimulating Factor
Recurrent Myeloid Sarcoma
University of WashingtonPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
24 Active assets in the Recurrent Myeloid Sarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid Kura Oncology, Inc. | Phase 3 | BB |
Mitoxantrone Ruijin Hospital | Phase 3 | BB |
Daunorubicin Kura Oncology, Inc. | Phase 3 | BB |
ETOPOSIDE St. Jude Children's Research Hospital | Phase 3 | BB |
Venetoclax Ruijin Hospital | Phase 2 | BB |
View all 32 →
Same molecule, other indications
Recombinant Human Granulocyte Colony-Stimulating Factor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →